Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Four of the top 10 drugs by prescription sales in 2025 will be from the new incretin class, according to the latest analysis by Evaluate. Consensus forecasts for Ozempic, Wegovy, Mounjaro and Zepbound ...

According to a September 2024 data brief from the Centers for Disease Control and Prevention (CDC), 40.3 percent of U.S.

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

Childhood obesity is on the rise and is becoming an epidemic in our country and worldwide. The consequences of childhood ...

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...

An international committee of scientists has proposed a change to the way obesity is defined and diagnosed. The goal is to ...

Is obesity a disease or a risk factor for disease? In medical circles – and outside of them – the question is contentious, ...

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular ...

Explore the pros and cons of BMI for men and women. Learn how Body Mass Index is calculated, what a healthy BMI range is, and ...

Get Wall Street's Hottest Chart Every Morning According to JP Morgan ... The conference is scheduled between 13 January and 16 January. Obesity is expected to remain a major focus for the industry.

Trends in the prevalence of hyperuricemia among adolescents in the US have remained stable over time, with prevalence significantly associated with obesity. A significant percentage of adolescents in ...